<SEC-DOCUMENT>0001062993-15-005723.txt : 20151103
<SEC-HEADER>0001062993-15-005723.hdr.sgml : 20151103
<ACCEPTANCE-DATETIME>20151103074302
ACCESSION NUMBER:		0001062993-15-005723
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20151103
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151103
DATE AS OF CHANGE:		20151103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXARIA CORP.
		CENTRAL INDEX KEY:			0001348362
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		IRS NUMBER:				202000871
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52138
		FILM NUMBER:		151192191

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 950, 1130 WEST PENDER STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 4A4
		BUSINESS PHONE:		604-602-1675

	MAIL ADDRESS:	
		STREET 1:		SUITE 950, 1130 WEST PENDER STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 4A4

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lexaria Corp.
		DATE OF NAME CHANGE:	20051229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
   <TITLE>Lexaria Corp.: Form 8-K - Filed by newsfilecorp.com</TITLE>
</HEAD>
<BODY style="font-size:10pt;">
<HR noshade align="center" width=100% size=3 color="black">
<A name=page_1></A>
<P align=center><B><FONT size=5>UNITED STATES </FONT></B><BR><B><FONT
size=5>SECURITIES AND EXCHANGE COMMISSION </FONT></B><BR><B>Washington, D.C.
20549 </B></P>
<P align=center><B><FONT size=5>FORM 8-K </FONT></B></P>
<P align=center>Current Report <BR>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 </P>
<DIV>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
borderColor=#000000 cellSpacing=0 cellPadding=3 width="100%" border=1>

  <TR vAlign=top>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=center colSpan=4>Date
      of Report (date of earliest event reported): <B><U>November 3, 2015
      </U></B></TD></TR>
  <TR vAlign=bottom>
    <TD align=center colSpan=4><FONT size=5><U>&nbsp;<B>LEXARIA
      CORP.</B>&nbsp; </U></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=center colSpan=4>(Exact
      name of registrant as specified in its charter) </TD></TR>
  <TR vAlign=top>
    <TD width="33%" rowSpan=3 align=center><U><B>Nevada </B></U><BR>
      (State or other
      jurisdiction of <BR>incorporation) </TD>
    <TD align=center width="33%" rowSpan=3><U><B>000-52138
      </B></U><BR>(Commission File Number) <BR></TD>
    <TD align=center width="34%" colSpan=2 rowSpan=3><U><B>20-2000871
      </B></U><BR>(IRS Employer Identification No.) </TD></TR>
  <TR vAlign=top></TR>
  <TR vAlign=top></TR>
  <TR vAlign=top>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=center colSpan=3>#950 &#150;
      1130 West Pender Street, Vancouver, British Columbia, Canada V6E 4A4 </TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=center
    width="20%">&nbsp;</TD>
  </TR>
  <TR vAlign=top>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=center
      colSpan=4>Registrant's telephone number, including area code: <B><U>(604)
      602-1675 </U></B></TD></TR>
  <TR vAlign=bottom>
    <TD align=center colSpan=4>(Former name or former address, if changed
      since last report.) </TD></TR></TABLE></DIV>
<P align=justify>Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions: </P>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD align=left>[&nbsp; ] </TD>
    <TD align=left width="95%">Written communications pursuant to Rule 425
      under the Securities Act (17 CFR 230.425) </TD></TR>
  <TR>
    <TD align=left >&nbsp;</TD>
    <TD align=left width="95%" >&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=left>[ &nbsp;] </TD>
    <TD align=left width="95%">Soliciting material pursuant to Rule 14a-12
      under the Exchange Act (17 CFR 240.14a-12) </TD></TR>
  <TR>
    <TD align=left >&nbsp;</TD>
    <TD align=left width="95%" >&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=left>[ &nbsp;] </TD>
    <TD align=left width="95%">Pre-commencement communications pursuant to
      Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD>
  </TR>
  <TR>
    <TD align=left >&nbsp;</TD>
    <TD align=left width="95%" >&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=left>[&nbsp; ] </TD>
    <TD align=left width="95%">Pre-commencement communications pursuant to
      Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
</TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_2></A>
<P align=justify><B>Item 7.01 Regulation FD Disclosure. </B></P>
<P align=justify>A copy of the news release announcing Lexaria Energy10 protein
bars are available for sale filed as exhibit 99.1 to this current report and is
hereby incorporated by reference. </P>
<P align=justify><B>ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. </B></P>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD vAlign=bottom noWrap align=center ><B>Exhibit No.</B> </TD>
    <TD vAlign=bottom noWrap align=center width="90%"><B>Description</B>
</TD></TR>
  <TR vAlign=top>
    <TD vAlign=bottom align=center bgColor=#eeeeee ><a href="exhibit99-1.htm">99.1 </a></TD>
    <TD vAlign=bottom align=center width="90%" bgColor=#eeeeee><a href="exhibit99-1.htm">News Release dated November 3, 2015 </a></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_3></A>
<P align=center><B>SIGNATURES </B></P>
<P align=justify>Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P>
<P align=justify>Dated: November 3, 2015 </P>
<DIV align=left>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=top>
    <TD align=left>&nbsp; </TD>
    <TD align=left width="80%" colSpan=2>Lexaria Corp. </TD></TR>
  <TR>
    <TD align=left >&nbsp;</TD>
    <TD align=left width="80%"  colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=left>(Signature) </TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left width="10%">By:
</TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left
      width="70%">&#147;<I>/s/ Chris Bunka&#148;</I> </TD></TR>
  <TR vAlign=top>
    <TD align=left>&nbsp; </TD>
    <TD align=left width="80%" colSpan=2>Chris Bunka </TD></TR>
  <TR vAlign=top>
    <TD align=left>&nbsp; </TD>
    <TD align=left width="80%" colSpan=2>CEO </TD></TR></TABLE></DIV><BR>
<HR align=center width="100%" color=black noShade SIZE=5>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
   <TITLE>Heritage Global Inc.: Exhibit 99.1 - Filed by newsfilecorp.com</TITLE>
</HEAD>
<BODY style="font-size:10pt;">
<HR noshade align="center" width=100% size=3 color="black">
<!--$$/page=--><A name=page_1></A>
<P align=justify><B>NEWS RELEASE </B></P>
<P align=center><B>Lexaria Protein Bar Available Now </B></P>
<P align=justify><B><I>Kelowna, BC&#151;November 3, 2015 - Lexaria Corp. (LXRP-OTCQB)
(LXX-CSE</I></B>) (the "Company" or "Lexaria") announces the brand new Lexaria
Energy10 Protein Bar is in stock and available for sale now at a new website:
<U>www.lexariaenergyfoods.com</U>. </P>
<P align=justify>Beginning immediately, Lexaria is launching a direct marketing
and sales campaign for the Lexaria Energy10 protein bars to roughly 250 select
gyms and fitness centers in the Western US. Feedback from this initial campaign
will be used to optimize the sales campaign to best acquire long term retail
points of sale. Lexaria then expects to roll-out its sales efforts beginning
with another roughly 2,000 pre-selected fitness centers across the US. </P>
<P align=justify>During the larger rollout Lexaria will also begin pursuit of
large regional and national fitness center accounts as we endeavour to make our
unique bars available to all gyms and health clubs across the country. Lexaria
has determined that, if it is capable of offering the bars for sale in roughly
25% of the nation&#146;s gyms and fitness clubs, annual sales of $39 million within
the fitness center channel alone would be possible. </P>
<P align=justify>The overall general strategy for distribution of the bars will
be to focus first on the fitness clubs and gyms (over 40,000 potential
locations); second on drugstores and pharmacies (over 67,000 potential
locations); third on convenience stores (over 152,000 potential locations); and
fourth on grocery and food retailers (over 30,000 potential locations). Other
distribution channels of interest include food service / restaurant / and
theatre locations (over 300,000); nutritional supplement stores (20,000); and
coffee / sandwich outlets (over 60,000).</P>
<P align=justify>Together, these retail channels offer orders of magnitude
greater distribution opportunities than other emerging sectors. The distribution
possibilities are extraordinary for a healthy food bar with unique,
patent-pending and technology-enhanced properties such as are offered by the
full spectrum hemp oil within the Lexaria Energy bars. </P>
<P align=justify>The Lexaria Energy10 bar is the world&#146;s first gluten free bar
fortified with active full spectrum hemp oil utilizing Lexaria&#146;s patent pending
technology for greater bioavailability. There are two different recipe
formulations being introduced, each optimized for a slightly different purpose.
</P>
<P align=center><IMG src="exhibit99-1x1x1.jpg" border=0> </P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_2></A>
<P align=justify>The Cashew Berry Date vegan bar is optimized for pre-workout or
morning use, with 10 grams of protein and a combination of dates, cherries and
blueberries for energy from natural sugar sources. This 70 gram bar delivers
energy for your workout or for your day to come. </P>
<P align=center><IMG src="exhibit99-1x2x1.jpg" border=0> </P>
<P align=justify>The Chocolate Berry Date bar is optimized for post-workout and
for afternoon or evening use, or anytime you have the munchies. It has an
astonishing 21 grams of protein and 13 grams of fiber to provide your body with
comfort and cleansing after strenuous activity. At 82 delicious grams it is
nearly a meal in itself. </P>
<P align=justify>Contingent on market demand, Lexaria will offer additional
flavors within these two recipe configurations, in 2016. </P>
<P align=justify>Despite being the only bars on the market fortified with patent
pending delivery technology for active hemp oil, and being some of the
physically largest bars on the market, the Lexaria Energy10 bars have a
manufacturer&#146;s suggested retail price of just US$3.99 &#150; about the same price as
other premium bars. This pricing represents a triumph of composition and
production technology, giving grocery shoppers access to active hemp oil
fortified products at about the same price as more traditional competitive
products that are NOT fortified with hemp oil. Fitness centers and gyms have
average memberships of more than 1,100 persons, all pursuing healthy active
lifestyles that the Lexaria Energy10 bars help fulfill. According to IHRSA,
there are 40,710 gyms and fitness centers in the USA today, and Lexaria intends
to ensure its unique protein bars are made available to as many as possible of
the 45 million Americans who have current health and fitness club
memberships.</P>
<P align=justify>We believe our strategy of focusing on this affluent niche will
help to establish the Lexaria Energy brand of active full spectrum hemp oil
infused performance products as a leader in the sector.</P>
<P align=justify><I>In vitro</I> laboratory testing completed in August 2015
determined that Lexaria&#146;s technology and formulation can result in cannabidiol
absorption rates in human intestinal tissues as much as 499% higher than
controls.</P>
<P align=justify>Health Club and gym owners, or other retailers interested in
offering this unique product, should call (1-843-952-3764 or 1-888-976-8482) to
place initial stocking orders or visit <U>www.lexariaenergyfoods.com</U>. The
bars are gluten free, all-natural with no artificial ingredients, no artificial flavors, no preservatives, no corn syrup, and no
added sugars (other than sweetened blueberries).</P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_3></A>

<P align=justify><B>About Lexaria </B></P>
<P align=justify>Lexaria is a food sciences company, with common shares quoted
in the USA with symbol LXRP and in Canada with symbol LXX. The company searches
for projects that could provide potential above-market returns.</P>
<P align=justify>To learn more about Lexaria Corp. visit
www.lexariaenergy.com.</P>
<P align=justify>FOR FURTHER INFORMATION PLEASE CONTACT:<BR>Lexaria
Corp.<BR>Chris Bunka<BR>Chairman &amp; CEO <BR>(250) 765-6424 </P>
<P align=justify>FORWARD-LOOKING STATEMENTS </P>
<P align=justify>This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements, including but not limited to:
achieving potential sales of $39 million through gyms and fitness centers, nor
achieving sales through any retail distribution channels such as drugstores,
grocery stores, etc. Such forward-looking statements are estimates reflecting
the Company's best judgment based upon current information and involve a number
of risks and uncertainties, and there can be no assurance that other factors
will not affect the accuracy of such forward-looking statements. Access to
capital, or lack thereof, is a major risk and there is no assurance that the
Company will be able to raise required working capital. Factors which could
cause actual results to differ materially from those estimated by the Company
include, but are not limited to, government regulation, managing and maintaining
growth, the effect of adverse publicity, litigation, competition, the patent
application and approval process and other factors which may be identified from
time to time in the Company's public announcements and filings. There is no
assurance that the medical marijuana, hemp oil sector, or alternative health
businesses will provide any benefit to Lexaria, or that the Company will
experience any growth through participation in these sectors. There is no
assurance that existing capital is sufficient for the Company's needs or that it
will not need to attempt to raise additional capital. There is no assurance that
any planned corporate activity, business venture, or initiative will be pursued,
or if pursued, will be successful. There is no assurance that any hemp oil or
cannabinoid-based product will promote, assist, or maintain any beneficial human
health conditions whatsoever. There is no assurance that the cannabinoid/lipid
infusion technology will provide any increase in bioavailability to any
individual person. There is no assurance that any patent application in the USA
or any other nation or under any treaty will result in the award of an actual
patent; nor that an award of any actual patent will protect against challenges
from unknown third parties. There is no assurance that any of Lexaria&#146;s
postulated uses, benefits, or advantages for the patent-pending technology will
in fact be realized in any manner or in any part. No statement herein has been
evaluated by the Food and Drug Administration (FDA). ViPova<SUP>TM</SUP>
products and Lexaria Energy products are not intended to diagnose, treat, cure
or prevent any disease.</P>
<P align=justify><I>The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release. </I></P>
<HR align=center width="100%" color=black noShade SIZE=5>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exhibit99-1x1x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x1x1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!# ! +# X,"A .#0X2$1 3&"@:&!86
M&#$C)1TH.C,]/#DS.#= 2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!# 1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P  1" "+ 4@# 2(  A$! Q$!_\0
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MT'_H"T5T0^%'G5OXC,OQ3_R&C_UR3_T(UCR?=D^K?S%;'BK_ )#1_P"N2?\
MH1K'D^[)]6_F*PEN=]+X$-B.+\GT=J34CC1Q[@?SIN[;=2'_ &FHU;C20/8?
MSI+=%5?@?H<SWI5)4Y4X-)172>2:%IJ\UO\ >59![\&M"+Q%-(P2&SW.>@#9
M_I6#&ADD5 <9.*ZK3(X+>/;$H!/5CU-7RNHK,RJ<L=;#;G3=2UG8;IK: )]U
M0"2/Q_\ KU4M]'O9[^2P-V3!  '=22%[A1GO6AJ6M1V43)$P:X(P .=ON?\
M"KNA8ATV)FR9)AYLC'DL3W/Z5YU1U*479>AM2FG;F*EMI\=_H\84;9XU\L.O
M#*R\=:Y*9IC(5G9RZG!#G)%:VGZ[)I^H7# >9;2RLQ3TR>HK/U.XCNM1GGB!
M"2.6&>M:THSC-J6QM4FI15BK111728!1110 4444 %%%% !1110 445J6&D-
M<PB>9BD9Z #EO?Z5+DHJ[ V/!26\4=Q=S8,I81(,9(]<5O30R._F;RFTAL=Z
MS[9$T_3X;6S0&XEP5W\X[DFKXGN6E5)X8MA3[\;'[P^M5["#?-+5FBJ22LAE
M]=(\!:0E@>J$[>?2H+&UCFA\]_\ 5C^$GI5#5)O.C<.0DJ#</?V-6]+E271_
M)W89N-Q'2K]C"]["525K7+45Q!%&D<68X6Z,GW1Z9]*J26O^E,^X^9CJ#FKT
M+6QMF?<2H&&#GI[&J"WT-G'NNID&250GGCG']*RQ%)./-%:FE&;4K,JSQ:E:
MW"W,1\Y"N&0#!(]JEO-1CGTYW7B9<+TY&>/P-7]/U;3K]#'',/,Z!&^4GZ9Z
MUS>NB.+7(L'!91O'XG&:XZ:;E9JQT.22NF6Y;N$621\, @!^N*HP2$(S1SRP
M@= &I71&!XQ]*KO$RX"G(KKL.3;9J:+#+>W+%YY !R3G-0/MAU5@PRK'OVJ7
M29)(@40[2YZBJ]S*LEV[*. <#\*$6[))F]':0S$)'C9*F2N>F/\ ]=4%4?9$
MPP^^O>J]O=FU1Y0<.5*I[DC_ ":='$OV#)&2"#42T)<>9D3N#.\*<@;BQ]\&
MK8_UC_[H_P#0#590/.D('4-_*K0_UC_[H_\ 0#4-W-8PY=#J/"'_ !XS_P#7
M0?\ H"T4>$/^/&?_ *Z#_P! 6BNB'PH\ZM_$9E^*O^0T?^N2?^A&L>3[LGU;
M^8K8\5?\AH_]<D_]"-8\GW9/JW\Q6$MV=]+X$5Y?]>_^^?YU)K/_ !XLOHHI
MCC-TP_VS_.I-1'F!D]1BI6YI-<RL<O12D$9SVI*ZCQQR,4;*]:E-Y<%=OFL!
M_L\5!11=H ZUM-KK)IT4$*XEV;&8]NW'O6+12$XI[A113XC'Y@\T$H.2!WIC
M&45+)Y1'R9Z+U^G/ZU*3:]0CYXX_'GOZ8HL*Y5HJU']FQ\Z,21T&>#4<J1%!
MY0;=QG(_S]:+!<BZ<&DJTGDF9VE1F!?(QZ9Y_2@+!D$HV.> *+!<K<GI259*
MH"I1&!V,&X[E<4@2/"Y!Z<\'VS_6BP[E>BK2K"" R$XZGD9X_P :"L.01&V-
MIR/?M3L*Y5KL].OM/N-/B,LZ12(H5D9PO0?RKF,6V!B)NO.<^G^-52ASTK.<
M%)#3N=W$\<LJ75LR3;5\H[6R!4TCK,AAC#HG#[PV#GKQ7#6-[<Z?*9+=MI/!
M!Z&M0^(W*<VWS_[_ !G\JWC))68%O5UQ%-<,_7J3W/85F:9JB0J$E^4>O.#5
M*\O;B]8&9N%^ZHX JM2<W?0#J9=7L_)PTBO_ +*J:PM1OS?2JVP(B#"KFHT^
MS>4N[.\=<YP>?\*3-OY?0[SGUP/2DY-@04=\YYJ9?LX4%LDX!P,\GO1B#8,'
MGY?7\?ZU $\=_P  2#_@0_PJR+F%N3*H'XU2C2W=02=I'WN>OYU712[!5!)/
M2@UC4DC4^UM(Q@M.XPTA'0>U3)!L0*&/'K3;2W%O'CJY^\:GK*4NQZ%.EI>>
MY&(@#DDM6C#\UK(/:JFPXS5FT.0R^HQ6;=S6R2T((OO-_NG^56Q_K'^@_P#0
M#52(89O]T_RJT/\ 6/\ [H_] - I;G4>$/\ CQG_ .N@_P#0%HH\(?\ 'C/_
M -=!_P"@+173#X4>76_B,S/%7_(:/_7)/_0C6/)]V3ZM_,5L>*O^0T?^N*?^
MA&L>3[LGU;^8K"6[.^E\"(AS>'_?/\ZE$9GN#CH.M1C_ (^I#Z%OYU=C=;.U
M).#._.WN*DU;.:U:%;:X:('DG<?H:H5KZC:2W#+,%)/1C446FC@RNJCW-=$7
M='EU8<LVC.P>U.6-VZ*:VH[:PC^_<1_]]"K*3:<GW,O_ +HS5&9@+:3-T0U.
MFEW#?P&MY;L?\L=/N'^D1IQN=3(S%HMV1_UP;_"@#&319SU6ITT*0]<U=:XU
MT_=T>['_ &[O_A43-XC;IIMVO_;NW^% #5T$CK4HT-1UQ4#6OB23_ERN_P#O
MT149TGQ&_P#RYW7_ 'SB@"Z-(B'5A^=._LN =77\ZH?\(_XB;_ERN?S'^- \
M->(3_P N,_XNO^- &A_9]L/^6B?G0+&U'_+5/SK/_P"$6\0G_EPD_P"_B?XT
MX>$O$)_Y<7_&5/\ &@"_]BM/^>J?G1]BM#_RU3\ZHCP?X@/_ "YG_O\ )_C3
MAX-\0?\ /J!_VV7_ !H N_8;7_GJGYT?8+4_\M$_.J8\&^(/^?9?^_R_XTO_
M  AOB'_GW7_O\O\ C0!;_LZV/_+1/SH_LN _Q+^=5/\ A#O$7_/ ?]_U_P :
M7_A$/$8_Y8#_ +_K_C0!8_L>(_Q+^=(=%C/<5#_PBGB4=(#_ -_U_P :7_A&
M/$Z](&_[_+_C0 XZ$IZ8J-M STIP\/\ BE>ELY_[:I_C2C1O%:_\NDG_ '\3
M_&@"NWA]ATJ%]!F'2M :?XJ3K8RG\5/]:<(?$R?>TZ8_\!!H QGT:Y7HM0/I
MMRO6,FNA#Z\OW](N3](B:DC?5'8*^C78SW\A@/Y4!:YROV68$+Y;$GMBM"SL
MS -[C]X>/I74Q02(,OIMR#W)A;_"F210,/GAD3ZH16,Y-Z([*--0=Y;F'16C
M+:VQ^Y*H]B:K/:LO*D,/8UF=RDF/L=LA,3=3TI[1&WNL=FZ54VO&P.""*O/.
M+NW4' GC.<?WA02]RFHQ+(/9OY59_P"6C_[H_P#0#4!_USGU4G]*G_Y:/_NC
M_P! - /<ZCPA_P >,_\ UT'_ * M%'A#_CQG_P"N@_\ 0%HKIA\*/,K?Q&.U
MC09=1OOM$<Z(-BKA@>Q)_K5%O"=RP8?:HADD_=/<Y_I7644G%,%6FE9,Y$>$
M;H.7^V0Y)SG8:MV_A*)3NN;N21O]A0O\\UT=%')$'7J/J9 \-:;C#QR2#N&D
M.#^ Q5B+1-+A'R:?;?4Q@G\S5^BJ,VV]R)+6WC^Y!$O^Z@%2XQTXI:*!"44M
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M )0:6DH 1E5A\P!^HJ%[*UD^_;0M]4%3T4!=HS)M TV;K;[?]UB*I3^$K*0?
MNY9HSVY!%=!12Y5V-%5FMF<D_@^;=E+Y2.GS1G/\Z=_PBEWDG[9#S_TS/ICU
J]*ZNBER1+^L5.YF:%IDFF6\D<DJR%WW J,8& /Z45IT52T,9-R=V?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>exhibit99-1x2x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x2x1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!# ! +# X,"A .#0X2$1 3&"@:&!86
M&#$C)1TH.C,]/#DS.#= 2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!# 1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P  1" ") 4@# 2(  A$! Q$!_\0
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M8<$\<TR"Z9)59\NH.2N<9H:LQO0[!M+TI@Q,,?&,X]Z9)HFE X:(*37-#5)
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MA\)E/<S=:_Y&&X_ZZI_Z"*S8^D?_  '_ -"-:>M?\C#<?]=4_P#0:S(^D?\
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M]^S_ (T 5/M>EK_&#^%)_:&F#O\ I5X?#F?OJ<?_ 'Y/^-.'PX?OJB_]^/\
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MH\?^\,5CJC;1F?:N8Y,.24/!%7KFU$3),G*GC-5V@V]#FIX;C$36\O*-T/\
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
